Despite a promising cash runway, ORIC Pharmaceuticals' cash ...
Despite a promising cash runway, ORIC Pharmaceuticals' cash burn relative to its market cap may pose future risks. If new shares are issued to fund operations, shareholders could face costly dilution. The cash burn is not a major concern currently, but shareholders need to pay attention.
Companies Like ORIC Pharmaceuticals (NASDAQ:ORIC) Are In A Position To Invest In Growth
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment